ArticleOncology reports2015

AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.

Yu-Xin Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.